Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A. · 2011
Read Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. by Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3140517.txt.
Introduction
Wanyang Liu and colleagues identified a gene behind a rare brain vessel disease in a 2011 paper in PLoS ONE. The disease narrows arteries at the base of the brain, mostly in East Asian families, and a suspect region on one chromosome was known but not the gene. The team combined family linkage mapping with full protein-coding scans.
One variant in a large gene stood out, shared by affected families on a common inherited background stretch. In a case-control study the variant carried a very large rise in disease risk, and further rare variants in the same gene appeared in Asian and European patients. The gene's normal roles include protein tagging, and silencing it in zebrafish distorted blood vessel growth. The work names a clear genetic suspect for the disease.
Catalog record
| CREATOR | Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A. |
|---|---|
| YEAR | 2011 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development By Wanyang Liu, Daisuke Morito, Seiji Takashima, Yohei Mineharu, Hatasu Kobayashi, Toshiaki Hitomi, Hirokuni Hashikata, Norio Matsuura, Satoru Yamazaki, Atsushi Toyoda, Ken-ichiro Kikuta, Yasushi Takagi Published in: PLoS ONE DOI: 10.1371/journal.pone.0022542 ABSTRACT Background Moyamoya disease is an idiopathic vascular disorder of intracranial arteries. Its susceptibility locus has been mapped to 17q25.3 in Japanese families, but the susceptibility gene is unknown. Methodology/Principal Findings Genome-wide linkage analysis in eight three-generation families with moyamoya disease revealed linkage to 17q25.3 (P<10-4). Fine mapping demonstrated a 1.5-Mb disease locus bounded by D17S1806 and rs2280147. We conducted exome analysis of the eight index cases in these families, with results filtered through Ng criteria. There was a variant of p.N321S in PCMTD1 and p.R4810K in RNF213 in the 1.5-Mb locus of the eight index cases. The p.N321S variant in PCMTD1 could not be confirmed by the Sanger method. Sequencing RNF213 in 42 index cases confirmed p.R4810K and revealed it to be the only unregistered variant. Genotyping 39 SNPs around RNF213 revealed a founder haplotype transmitted in 42 families. Sequencing the 260-kb region covering the founder haplotype in one index case did not show any coding variants except p.R4810K. A case-control study demonstrated strong association of p.R4810K with moyamoya disease in East Asian populations (251 cases and 707 controls) with an odds ratio of 111.8 (P = 10−119). Sequencing of RNF213 in East Asian cases revealed additional novel variants: p.D4863N, p.E4950D, p.A5021V, p.D5160E, and p.E5176G. Among Caucasian cases, variants p.N3962D, p.D4013N, p.R4062Q and p.P4608S were identified. RNF213 encodes a 591-kDa cytosolic protein that possesses two functional domains: a Walker motif and a RING finger domain. These exhibit ATPase and ubiquitin ligase activities. Although the mutant alleles (p.R4810K or p.D4013N in the RING domain) did not affect transcription levels or ubiquitination activity, knockdown of RNF213 in zebrafish caused irregular wall formation in trunk arteries and abnormal sprouting vessels. Conclusions/Significance We provide evidence suggesting, for the first time, the involvement of RNF213 in genetic susceptibility to moyamoya disease. INTRODUCTION Moyamoya disease is an idiopathic disorder characterized by occlusive lesions in the supraclinoid internal carotid artery and its main branches in the circle of Willis. To compensate for the blood flow around the occlusive region, a fine vascular network develops that resembles “puffs of smoke” (Figure 1A) [1]. The unique appearance of moyamoya vessels described by Suzuki and Takaku in 1969 [2] spurred international recognition of moyamoya disease [MIM 607151] (Online Mendelian Inheritance in Man in Appendix S1). Moyamoya disease occurs worldwide [3], but its prevalence is highest in East Asian countries, including Japan (1 in 10,000), Korea and China [4], [5]. It is known to cause stroke in neonates and children, and therefore pathological clues for early diagnosis and novel therapeutic approaches are needed [6]. [Figure: Clinical features of moyamoya disease.(A) An anterior-posterior and lateral views of left internal carotid angiography in a 9-year-old child with moyamoya disease (right) and an 8-year-old control child (left). An occlusion with moyamoya vessels can be seen around the terminal portion of the internal carotid artery and proximal portions of the anterior cerebral artery and middle cerebral artery in the affected child. (B) Intimal hyperplasia in the middle cerebral artery from an autopsy of a 69-year-old case. Intimal hyperplasia (red arrowhead), atrophic media (red arrow) and winding internal elastic lamina (black arrow) can be seen with Elastica Masson staining, ×200.] The occlusive lesions are caused by excessive proliferation of smooth muscle cells (SMCs), which specifically occurs in arteries in the skull with compensatory bypass vessels (Figure 1B) [7]. These occlusive lesions are similar to those of atherosclerosis in that both types of lesion exhibit endothelial injury, SMC proliferation and intimal hyperplasia. However, there are major differences between the two types: in moyamoya vessels, infiltrating cellular components such as macrophages and lipid deposits are not observed [8]. A recent study revealed that accelerated vascular remodeling might underlie the pathological consequences of moyamoya disease [9]. Clinical investigations have revealed elevated levels of certain growth factors or cytokines in the cerebrospinal fluid, serum or blood vessels of patients with moyamoya disease [10]–[15]. These factors are assumed to be associated with vascular remodeling. Epidemiological studies have revealed several risk factors associated with moyamoya disease, including Asian ethnicity, female gender and a family history of the disease [4]. Given that 15% of moyamoya patients have a family history of the disease, genetic factors are suspected to underlie its pathogenesis. Several studies have explored genetic factors and revealed four loci associated with moyamoya disease: 3p24–p26 [16], 6q25 [17], 8q23 [18] and 17q25 [19]. The locus on 17q25, first mapped by Yamauchi et al. [19], was replicated in 2008 [20], [21]. In our previous study, a strong association of a variant (ss161110142) was demonstrated in East Asian patients, suggesting a possible East Asian founder haplotype for moyamoya disease [21]. The major aim of the present study was to identify the causative gene for moyamoya disease. In the present study, we conducted exome analysis and identified ring finger protein 213 (RNF213; DDBJ/EMBL/GenBank accession number AB537889) [National Center for Biotechnology Information (NCBI) in Appendix S1] as a susceptibility gene. In this study, we cloned RNF213 and determined its open reading frame (ORF). Compared with the previously registered RNF213 sequence [NM_020914.4] (NCBI in Appendix S1), our RNF213 clone possesses a 2,500-bp longer 3′ untranslated region (UTR) and lacks exon 4. Since we found that AB537889 seems to be the major transcript of RNF213, the descriptions of RNF213 in this paper are primarily based on the newly determined ORF unless otherwise stated. METHODS Ethical statement Ethical approval for this study was given by the Institutional Review Board and Ethics Committee of Kyoto University School of Medicine, Kyoto University, Japan (approval number: G140; approval date: 10/18/2004); by the Ethics Committee of the medical faculty of the University of Tübingen (Ethik-Kommission der Medizinischen Fakultät des Universitätsklinikums Tübingen; permit number: 273/2009BO1; approval date: 1/1/2009); by Seoul National University Hospital Institutional Review Board (approval number: H0507-509-153; approval date 8/24/2005); by the Medical Ethics Committee of Beijing Children's Hospital Institutional Review Board, Capital Medical University, China (approval number: 2005-31; approval date: 3/15/2005); and by the Ethics Committee of University Hospital and the Faculty of Medicine of Palacky University in Olomouc (reference number: 62/10; approval date: 8/18/2008). Participants were recruited in these institutes. All subjects gave written informed consent, or for those considered too young to consent, informed consent was given by their parent or guardian. Subjects Diagnostic criteria were based on the Japanese Research Committee on moyamoya disease of the Ministry of Health, Welfare and Labour, Japan (RCMJ) criteria [22]. Information on family histories, gender, age of onset, onset of symptoms and unilateral or bilateral moyamoya disease was obtained either by interview or by clinical chart review, as previously reported [21], [23]. We recruited East Asian cases (Japanese, Korean and Chinese), as described previously [21]. The participants comprised 41 Japanese families and one Korean family (Figure S1 and Table S1), 209 unrelated cases (120 Japanese, 37 Korean and 52 Chinese). We recruited 757 unrelated controls: 384 Japanese, 223 Korean and 100 Chinese (Table S2) and an additional 50 Chinese adult females [Mean age